Objective-We analyzed the role of caveolin-1 (Cav-1) in the cross-talk between NADPH oxidase and endothelial nitric oxide synthase (eNOS) signaling in endothelial caveolae.
R educed bioavailability of endothelium-derived nitric oxide (NO), a key regulator of vascular homeostasis, is a hallmark of endothelial dysfunction, a recognized risk factor for cardiovascular diseases. Many of these diseases (eg, hypertension and diabetes) are associated with activation of the renin-angiotensin system. 1 Its effector, angiotensin II (AII), activates vascular NADPH oxidase, one of the main cellular sources of superoxide anion radicals (O 2 Ϫ⅐ ) that perpetuates a second cascade of signaling events triggered by reactive oxygen species (ROS) formation. 2, 3 In the course of these events, impairment of endothelial NO bioavailability is caused by scavenger reactions with O 2
Ϫ⅐ or inhibition of the endothelial NO synthase (eNOS) (eg, by ROS-activated PYK2 4 ). Moreover, the activity of eNOS can shift from NO to O 2 Ϫ⅐ production (ie, eNOS "uncoupling") in case of shortage of its substrate, L-arginine; oxidation of the cofactor (6R)-5,6,7,8-tetrahydrobiopterin or of eNOS itself; changes of the eNOS phosphorylation pattern; or disruption of the protein-protein interaction (eg, with hsp90 5-7 ), all of which may be caused by ROS production. 8, 9 On the other hand, increasing evidence suggests a signaling role for ROS in the vasculature beyond NO scavenging. For example, short-time exposure of endothelial cells (ECs) to AII (30 minutes) increases eNOS activity (and NO production) via AT 1 receptor/NADPH oxidase; in this setting, hydrogen peroxide resulting from superoxide dismutation has been proposed as a mediator of eNOS activation. 10 Spatial compartmentation may be one explanation for this apparent paradox, but it has been very little explored in the context of the cross-talk between NO and ROS in ECs. 11 eNOS is a well-known "resident" of endothelial caveolae, where its activity is tightly regulated by its interaction with the structural caveolar protein, caveolin-1 (Cav-1). 12, 13 The mechanism(s) of NADPH oxidase activation by AII has been more intensively studied in vascular smooth muscle. The assembly of a functional enzyme requires at least 2 main membrane components: one of the NADPH oxidase (NOX) homologs (such as gp91phox, or NOX2; NOX1; and NOX4, all identified in the endothelium) and p22phox, a stabilizer. Activation of NOX2/NOX1 requires the additional association of the cytosolic p47phox, an organizer of its functional assembly, and of the activator p67phox, which were shown to translocate to the membrane after stimulation. 14 Recent evidence suggests that this multisubunit assembly might take place in caveolin-enriched membrane fractions, ie, endothelial rafts/caveolae. 15 However, a role for Cav-1 in orchestrating the interaction between NO and ROS from eNOS and NADPH oxidase in rafts/ caveolae following activation by AII was never investigated. This is important because (1) Cav-1 abundance is known to be regulated by disease states, and in particular, we showed that its increase in ECs in hypercholesterolemic states causes NO-dependent endothelial dysfunction 16 ; and (2) moderate downregulation of Cav-1 (as obtained with therapeutic concentrations of statins) potentiates eNOS activation. 17, 18 Therefore, we hypothesized that Cav-1 abundance may critically control the assembly of caveolar signalosomes containing both eNOS and NADPH oxidase on AII stimulation of ECs and that its downregulation may decrease ROS production while maintaining NOS activity, thereby tilting the balance toward preserved NO production and bioavailability.
Materials and Methods

Materials and Cell Cultures
All chemicals of ultrahigh grade were purchased from Sigma-Aldrich Chemical Inc or Alexis Biochemical Inc. Primary cultures of human umbilical vein ECs (HUVECs) and bovine aortic ECs (BAECs) were purchased from Clonetics (Lonza, Switzerland). Murine ECs were isolated from aortas of mice haploinsufficient for Cav-1 (Cav-1 ϩ/Ϫ ) and wild-type littermates of the same C57Bl6 background (Cav-1 ϩ/ϩ ). For details, see the Supplemental Data, available online at http://atvb.ahajournals.org.
Animals
Male 16-week-old mice, Cav-1 ϩ/Ϫ and Cav-1 ϩ/ϩ , were anesthetized and implanted with miniaturized telemetry devices (Datascience Corp) and osmotic minipumps (model 2002, Alzet) for AII delivery (1.1 mg/kg per day) or saline as described previously 19 and in the Supplemental Data. Mice were injected with heparin and anesthetized, and venous blood was obtained by a puncture of the right ventricle, immediately frozen in calibrated tubes (0.2 mL) at 77 K, and processed for electron paramagnetic resonance (EPR) measurements. Experiments conformed with the Guide for the Care and Use of Laboratory Animals and with the recommendations of the local ethics committee.
Small Interfering RNA Transfection
RNA oligonucleotides complementary to Cav-1 and cAbl target sequences (Qiagen) were used to silence respective gene expression. A detailed description of the construction, transfection, and control small interfering RNA (siRNA) is available in the Supplemental Data.
Purification of Caveolae-Enriched Membrane Fractions
Caveolin-enriched membranes were isolated by isopycnic ultracentrifugation of lysates of ECs against sucrose gradient (35% to 5%) as described previously. 20 The fractions were collected (0.5 mL each), tested for NADPH oxidase activity by EPR spin trapping with 5.5-dimythyl-1-pyrolline-N-oxide (DMPO), and concentrated for immunoblotting. A detailed description of the protocols for cell fractionation is available in the Supplemental Data.
Immunoprecipitation and Immunoblotting
Cells were lysed with cold lysis buffer, homogenized, and analyzed with appropriate antibodies as described previously. 21 For eNOS monomer/dimer assay, nondenatured cell lysates in ice-cold buffer were separated by low-temperature SDS-PAGE for immunoblotting. Signals were quantified by densitometry, normalized to loading control, and expressed as ratio of monomeric/monomericϩdimeric eNOS. A detailed description of these assays is available in the Supplemental Data.
Immunofluorescence Microscopy and Proximity Ligation Assay In Situ
Confluent HUVECs were preincubated with low-serum medium and stimulated or not with AII before fixation. Then cells were permeabilized, washed, incubated with 5% of bovine serum albumin, and then consistently incubated with the appropriate antibodies. Species-specific secondary antibodies (Alexa and DyLight IgG) for immunocytochemistry or Duolink proximity ligation assay (PLA) probes (Olink Bioscience, Sweden) were added according to the manufacturers' protocols. Colocalized p47phox and Cav-1 bound to the specific antibodies were detected using oligonucleotidelabeled secondary antibodies after reporter DNA molecule circularization with a size-limiting linker oligonucleotide, ligation, and rolling circle amplification. Amplified reporter DNA was detected using complementary fluorescent probes. After nuclear staining with Hoechst 33342 and cytoskeleton with phalloidin, images were acquired with a ZeissImager.Z1 fluorescence microscope equipped with an ApoTome device using ϫ20, ϫ40, or ϫ63 oil-immersion objective lenses and analyzed with AxioVision and Duolink BlobFinder software. A detailed description of the protocols is available in the Supplemental Data.
Measurements of NO and Superoxide Anions by EPR
Bioavailable NO was assayed by EPR spin trapping in ECs as previously reported. 21, 22 Briefly, serum-starved cells (treated with AII with/without inhibitors or the respective vehicle) were incubated with a colloid solution of the NO spin trap, diethyldithiocarbamate-iron complex in culture dishes in a CO 2 incubator. After medium removal, cells were scraped on ice, and extracts were frozen in calibrated tubes in liquid nitrogen. The formed paramagnetic NO-adduct, accumulated at plasma cell membranes, was assayed by a Bruker EMX100 spectrometer.
The level of circulating heme-nitrosylate hemoglobin (Hb-NO) was assayed in whole blood of mice from the EPR signal of 5-coordinate-␣-Hb-NO as described previously. 19 The EPR spectra of whole blood were recorded by a Bruker EMX100 spectrometer. The level of Hb-NO was quantified from hyperfine structure of the signal after subtraction of EPR signal of free radicals using Microcal Origin software.
Extracellular O 2 Ϫ⅐ formation was assayed by EPR spin trapping using DMPO (high purity, Alexis) after charcoal filtration as described previously. 23 Cells were preincubated in Krebs-DTPA-Hepes buffer with pharmacological reagents or vehicle and stimulated (or not) with AII in the presence of DMPO (60 mmol/L) at 37°C in a CO 2 incubator. The extracellular medium was transferred in a capillary for immediate measurement of formed paramagnetic adducts by a Bruker EMX100.
The details of the protocols, EPR parameters and spectrum characteristics are available in the Supplemental Data.
Statistical Analysis
Data are presented as mean valuesϮstandard error. Statistical significance was assessed by group comparison using 1-way or 2-way ANOVA, where appropriate (Microcal Origin). Results were considered significant at PϽ0.05.
Results
AII Activates the Concurrent Production of NO and O 2 ؊⅐ in ECs With Ensuing eNOS Uncoupling
We first analyzed NO formation in the membranes of intact ECs by EPR spectroscopy using colloidal spin trapping agents. NO production, assayed by EPR as accumulated paramagnetic complex of nitrosylated [Fe(II)(DETC) 2 ], was increased to 158Ϯ12% of basal level after 30 minutes of stimulation of ECs with AII (2 mol/L). This increase was abrogated on incubation with the NOS inhibitor, N-nitro-L-arginine methyl ester (L-NAME) ( Figure 1A ). Typical EPR spectra obtained after stimulation of ECs (Ϸ2ϫ10 6 ) by AII are shown on Figure 1B . The NO signal is increased on incubation of ECs with superoxide dismutase (SOD), suggesting scavenging of the NO radical by O 2
Ϫ⅐ concurrently produced at the membrane. Indeed, AII-stimulated NO production was potentiated to 314Ϯ14% of baseline after 30 minutes of preincubation of ECs with polyethylene glycol-conjugated SOD (PEG-SOD) ( Figure  1C ). This time was shown to be sufficient for the association of PEG-SOD to the plasma membrane. 24 A similar potentiation of AII-stimulated NO formation was observed in cells pretreated 30 minutes with the SOD mimetic MnTBAP (Supplemental Figure IA and Figure 1B ).
We next applied EPR spin trapping using DMPO to monitor extracellular superoxide anion formation from intact ECs. Stimulation with AII (30 minutes) also increased O 2
Ϫ⅐ production to 209Ϯ5% of basal level in the cell supernatant ( Figure 1D ). Incubation with SOD strongly suppressed the EPR signal, confirming that the observed paramagnetic DMPO-OH radicals mostly resulted from the reaction with O 2 Ϫ⅐ Accumulated EPR spectra obtained after stimulation of ECs (Ϸ1ϫ10 6 ) are shown on Figure 1E . Notably, L-NAME (which inhibited NO production, Figure  1A ) also partly diminished the O 2
Ϫ⅐ signal in AIIstimulated ECs ( Figure 1D ). This is contrary to the expectation if NO scavenged only O 2
Ϫ⅐ production directly from the NOS electron chain in uncoupled eNOS, which is known to be inhibited by L-NAME, 23 as observed here under conditions of concurrent NO and O 2
Ϫ⅐ production after AII short-term stimulation.
To confirm eNOS uncoupling, we assayed the monomer/dimer ratio of eNOS proteins by Western blotting in nonreducing conditions. We found that the ratio of monomer/(dimerϩmonomer) proteins increased by 35% over control (nϭ6; PϽ0,05) after 30 minutes of cell stimulation with AII ( Figure 1F ). eNOS uncoupling was previously described to be associated with specific alterations in phosphorylation patterns. Accordingly, we observed combined eNOS dephosphorylation at Thr495 and Ser1177, despite clearly activated upstream kinases for the latter (ie, Ϫ⅐ production and promotes eNOS uncoupling. Production of NO at the membrane (A) and extracellular production of O 2 Ϫ⅐ (D) were measured by EPR spin trapping from intact BAECs with or without N-nitro-L-arginine methyl ester (L-NAME) (2 mmol/L, 30 minutes) or CuZn-SOD (150 U/mL) and stimulation with AII (2 mol/L, 30 minutes; nϭ3 to 10). Cntl indicates control. B, Typical EPR spectra (with [Fe(II)(DETC) 2 ] of untreated (control) and AII-treated BAECs, with or without MnTBAP (100 mol/L), or L-NAME (2 mmol/L). C, Effect of PEG-SOD (70 U/mL, 30 minutes) on AII-stimulated NO production in BAECs (measured as in A). nϭ3 to 10. *PϽ0.05 between conditions. E, Typical accumulated EPR spectra (with DMPO) of untreated (control) and AII-treated BAECs, with or without CuZn-SOD (150 U/mL). F, Representative eNOS immunoblotting signals from nondenatured EC lysates with or without AII (as in A) or H 2 O 2 (5 mmol/L, 15 minutes); densitometric analysis of eNOS monomer/ (dimerϩmonomer) ratio, quantified from 6 independent preparations is shown below. *PϽ0.05 between conditions analyzed by 1-tailed Wilcoxon test. phosphatidylinositol 3-kinase/Akt; Supplemental Figure IIA to IID), a pattern previously associated with eNOS uncoupling. 25 It also suggested the involvement of phosphatases (to dephosphorylate Ser1177/1179), as supported from the effect of okadaic acid, an inhibitor of protein phosphatases 1 and 2A, 26 which restored AII-stimulated phosphorylation of eNOS at Ser1177 (Supplemental Figure IID) . Altogether, the phosphorylation pattern, shift to the monomeric form of eNOS, and L-NAME sensitivity of O 2
Ϫ ⅐ production strongly indicate eNOS uncoupling.
Redox-Sensitive Pathway of eNOS Activation by AII: Critical Role of cAbl
Although oxidant species resulting from the simultaneous formation of NO and O 2
Ϫ⅐ can uncouple eNOS and decrease NO bioavailability at the membrane, as illustrated above, they may also activate intracellular signaling through redox-sensitive kinases implicated in eNOS activation by ROS. 4 Indeed, in our ECs, preincubation with a water-soluble cell-permeating antioxidant, Trolox, abrogated the AII-stimulated NO signal (Supplemental Figure IA) , in contrast to the effects of SOD shown above ( Figure 1C ). Conversely, on stimulation of ECs with the Ca 2ϩ ionophore A23187, all antioxidants consistently and exclusively increased the NO signal (Supplemental Figure IB) , indicating specific ROS-dependent signaling downstream AII receptor activation.
To study redox-sensitive signaling elements for eNOS activation by AII, ECs were treated with an inhibitor of phosphatidylinositol 3-kinases, LY294002, and apocynin, an inhibitor of NADPH oxidase assembly. Both agents decreased AII-stimulated extracellular O 2
Ϫ⅐ and, notably, also NO production in ECs (Figure 2A and 2B ). We then tested the involvement of the redox-sensitive c-Src and cAbl tyrosine kinases using an inhibitor of nonreceptor c-Src kinase, (4-amino-5-(4-chlorophenyl)-7-(tbutyl)pyrazolo [3,4-d] pyrimidine), and siRNA targeting cAbl, respectively. (4-amino-5-(4-chlorophenyl)-7-(tbutyl)pyrazolo[3,4-d]pyrimidine) fully suppressed NO formation stimulated by AII ( Figure 2C) . Similarly, AIIstimulated NO production was strongly inhibited in ECs ( Figure 2D ) after siRNA downregulation of cAbl (by more than 60%, Figure 2E ) but not with control siRNA ( Figure 2D ).
AII Induces Colocalization of eNOS, cAbl, and p47phox and Assembly of NADPH Oxidase in Low-Density, Caveolin-Rich Membrane Fractions
We next examined whether such redox signaling was influenced by compartmentation of the 2 enzymatic systems.
To analyze the colocalization of Cav-1 and p47phox, a critical organizer of NADPH-oxidase assembly, in intact EC, we used a PLA combined with fluorescence microscopy, where fluorescent dots quantitatively reflect physical proximity of 2 different immunodetected proteins. In resting cells, a low PLA signal indicated some colocalization between the 2 proteins; however, the signal doubled after 15 minutes of AII stimulation ( Figure 3A and 3B; nϭ3 ; PϽ0.05).
To further analyze spatial compartmentation of eNOS and NADPH oxidase, total homogenates of ECs, stimulated or not with AII, were separated on a multiplestep discontinuous sucrose density gradient and each fraction analyzed for NADPH oxidase activity ( Figure  3D ) and by immunoblotting ( Figure 3F ). NADPH oxidase activity was measured in all fractions from unstimulated cells and in fractions from AII-stimulated cells. A typical result is presented in Figure 3D , and mean values normalized to protein content in lowdensity (LD) and high-density (HD) fractions are shown in Figure 3E . On AII stimulation, a peak of NADPH oxidase activity was observed in LD fractions, corresponding to caveolin-1-enriched fractions, as identified by immunoblotting ( Figure 3F, left) . This indicated the assembly of a functional NADPH oxidase on AII stimulation in caveolin-rich membrane fractions where eNOS is colocalized ( Figure 3F 
Cav-1 Downregulation Inhibits p47phox Recruitment and NADPH Oxidase Activation in LD, Caveolin-Rich Membrane Fractions While Preserving eNOS Confinement
Next, we analyzed the effect of moderate Cav-1 downregulation on the distribution of the above proteins in ECs stimulated with AII. Transfection with anti-Cav-1 siRNA (to reduce Cav-1 abundance by Ϸ50%, see Figure 4C ) abrogated the peak of NADPH oxidase activity in LD fractions of cells stimulated by AII, whereas it was unaffected in cells transfected with control siRNA ( Figure 3E) . Notably, Cav-1 downregulation altered the translocation of p47phox after AII, which decreased in the caveolin-rich fractions ( Figure  3F , right, and 3G). This was confirmed by a separate analysis of the membrane distribution of p47phox, which decreased in cells transfected with Cav-1 siRNA (Supplemental Figure IVC) , and by PLA in intact cells, Ϫ⅐ production (EPR spin trapping) in intact HUVECs, transfected with control or Cav-1 targeted siRNA and pretreated with N-nitro-L-arginine methyl ester (L-NAME) (2 mmol/L) or vehicle (30 minutes) before stimulation by AII (2 mol/L, 30 minutes; nϭ6 to 7; *PϽ0.05 between different conditions). Cntl indicates control. B, NO production (EPR spin trapping) in intact BAECs transfected with control or Cav-1 targeted siRNA and pretreated with PEG-SOD (30 minutes) or vehicle before stimulation by AII (2 mol/L, 30 minutes; nϭ3 to 5). C, Representative immunoblotting signals for Cav-1 (and ␤-actin) and densitometric analysis from ECs lysates transfected or not with Cav-1 siRNA. (nϭ7). *PϽ0.05 between conditions. where the colocalization signal was abrogated after Cav-1 downregulation ( Figure 3C ; for higher magnification, see Supplemental Figure VA ). This indicates that the recruitment of p47phox and assembly of functional NADPH oxidase in caveolin-rich membrane fractions is critically modulated by Cav-1 abundance. Conversely, Cav-1 downregulation did not alter the level of eNOS in LD fractions in AII-stimulated cells ( Figure 3F ).
Cav-1 Downregulation Inhibits O 2 ؊⅐ and Reverses eNOS Uncoupling at the Membrane of AII-Treated ECs
We next examined the impact of Cav-1 downregulation on O 2
Ϫ⅐ and NO bioavailability at the membrane of intact cells. Consistent with measurements in cell fractions ( Figure 3E) , transfection with anti-Cav-1 siRNA inhibited AII-stimulated O 2 Ϫ⅐ production ( Figure 4A , right); it also reduced (but did not abrogate) NO production stimulated by AII ( Figure 4B ), as expected from its O 2
Ϫ⅐ dependence (see Figure 2B and Supplemental Figure IA) . Importantly, it also abolished the effect of PEG-SOD preincubation on AII-stimulated NO production. This suggests that the NO signal at the membrane was less sensitive to O 2
Ϫ⅐ after Cav-1 downregulation, consistent with reduced assembly of NADPH oxidase as observed above. To assess the impact on eNOS uncoupling, we measured the L-NAMEsensitive production of O 2
Ϫ⅐
. As previously illustrated in Figure 1D , in control cells, the AII-stimulated O 2
Ϫ⅐ production was inhibited by L-NAME, indicating functional eNOS uncoupling ( Figure 4A, left) . This L-NAMEsensitive production of O 2
Ϫ⅐ was abrogated after Cav-1 downregulation; instead, L-NAME treatment increased the O 2
Ϫ⅐ signal after AII stimulation ( Figure 4A, right) , as expected from inhibition of NO production from a functional eNOS.
Cav-1 Downregulation Prevents AII-Induced Hypertension and Preserves Circulating Hb-NO Levels In Vivo
To extend the functional relevance of these observations in vivo, we examined the impact of a similar moderate downregulation of Cav-1 using Cav-1 ϩ/Ϫ haploinsufficient mice. First, we verified that Cav-1 was downregulated in aortic extracts of Cav-1 ϩ/Ϫ to 53Ϯ7% of the level in Cav-1 ϩ/ϩ ( Figure 5C ). Then, we analyzed the colocalization of Cav-1 and p47phox in murine aortic ECs by PLA and observed that the PLA signal was suppressed in Cav-1 ϩ/Ϫ ECs ( Figure 5A and 5B, left) and, contrary to control cells, was not increased under AII stimulation ( Figure 5A and 5B, right, and 5D). Furthermore, we assayed circulating NO bioavailability and systolic blood pressure regulation in heterozygote Cav-1 ϩ/Ϫ mice and their Cav-1 ϩ/ϩ littermates after 1 week of AII (or vehicle) administration by osmotic mimipumps. In Cav-1 ϩ/ϩ mice, systolic blood pressure measured by implanted telemetry before and after 1 week of AII infusion significantly increased (from 115.3Ϯ1.5 to 134.6Ϯ3.5 mm Hg); in parallel, blood levels of the 5-coordinate-␣-Hb-NO complex, measured by EPR as an index of vascular NO bioavailability, decreased to 55Ϯ15% of control ( Figure 5E and 5F, left). Conversely, the increase in systolic blood pressure was significantly lower in Cav-1 ϩ/Ϫ mice under AII infusion (8.9Ϯ3.1 compared with 19.3Ϯ3.4 mm Hg in Cav ϩ/ϩ mice), and NO bioavailability measured as Hb-NO level was unchanged ( Figure 5E and 5F, right).
Discussion
Our data show that (1) AII activates both NO and ROS production in EC, and the latter both reduces NO bioavailability at the membrane but mediates AII signaling to eNOS through ROS-sensitive Src and cAbl tyrosine kinases; (2) Cav-1 mediates the recruitment of Figure 5 . Moderate Cav-1 downregulation prevents AII-induced p47phox and Cav-1 interaction in mouse ECs in vitro, preserves NO bioavailability, and prevents hypertension development in haploinsufficient Cav-1 ϩ/Ϫ mice in vivo. A and B, PLA signal (red dots) of Cav-1 and p47phox interaction in aortic ECs isolated from haploinsufficient Cav-1 ϩ/Ϫ mice (B) and WT littermate (A) and treated with/without AII (DAPI for nuclei staining in blue; cytoskeleton in green; nuclear dots represent non specific binding of trapped antibodies). Images were obtained using a ϫ40 objective lens. C, Representative immunoblotting signals for Cav-1 (and ␤-actin) from aortic extracts of Cav-1 ϩ/ϩ and Cav-1 ϩ/Ϫ mice and densitometric analysis (nϭ4). D, Quantitation of PLA signals from nϭ3 to 6 independent experiments as illustrated in A and B. *PϽ0.05 between conditions. E, Systolic blood pressure measured by implanted telemetry in conscious Cav-1 ϩ/Ϫ and Cav-1 ϩ/ϩ mice before and after 1 week of AII infusion (1.1 mg/kg per day) or saline (nϭ7 mice each). F, Level of hemoglobin (Hb)-NO (as 5-coordinate-␣-HbNO complex, by EPR) in venous blood of Cav-1 ϩ/Ϫ and Cav-1 ϩ/ϩ mice after 1 week of AII infusion as in E (nϭ5 mice each). *PϽ0.05 between conditions. Cntl indicates control.
cAbl and p47phox and the assembly of a functional NADPH oxidase by AII in caveolin-rich membrane fractions, where eNOS is colocalized; (3) colocalization of AII-activated eNOS and NADPH oxidase promotes eNOS uncoupling; and (4) moderate downregulation of Cav-1 prevents all of the above while maintaining NO bioavailability in vitro and in vivo.
Our model, as summarized in Figure 6 , shows that although oxidant species resulting from the simultaneous formation of NO and O 2
Ϫ⅐ can uncouple eNOS and decrease NO bioavailability at the membrane, they may also activate intracellular signaling through redoxsensitive kinases implicated in eNOS activation by ROS. 4, 26 These results are consistent with previous demonstrations of eNOS activation by NADPH oxidase-derived oxidants, such as H 2 O 2 , 10 and more recently by overexpression of NOX5 in ECs. 27 In the latter study, as in ours ( Figure 1C) , the ROS-mediated production of NO was potentiated on incubation with extracellular SOD, suggesting a dual effect of ROS to decrease bioavailability of NO at the cell surface but activating eNOS through intracellular ROS signaling. Our study adds the identification of cAbl as critical for AII-mediated activation of eNOS, which may have implications for the mechanistic understanding of vascular side effects of new anticancer drugs targeting this and other tyrosine kinases. 28 Previous studies, including ours, demonstrated basal interaction of eNOS and Cav-1 16, 17 in endothelial caveolae; however, the role of Cav-1 in NADPH-oxidase assembly and activation in ECs remained poorly defined. We now demonstrate that the recruitment of p47phox and assembly of functional NADPH oxidase in caveolin-rich membrane fractions is critically modulated by Cav-1 abundance. Conversely, Cav-1 downregulation did not alter the confinement of eNOS in LD fractions in AII-stimulated cells ( Figure 3F) , consistent with the predominant role of eNOS prenylation for membrane anchoring. 29 Our data further demonstrate that colocalization of NADPH oxidase with eNOS in Cav-1-rich rafts/caveolae both sustains ROS-mediated activation of eNOS by AII and simultaneously promotes eNOS uncoupling (see Figure 6 , lower left). The latter can be reversed by downregulating of Cav-1 while maintaining a functional eNOS at the membrane (Figure 6 , lower right).
Partial downregulation of endothelial Cav-1 may then confer the double advantage of increasing NO output with vasodilators and reducing eNOS uncoupling through attenuation of NADPH oxidase assembly and activation in response to AII (and possibly other prooxidant agonists). We previously showed that similar moderate reductions of Cav-1 expression are associated with a potentiation of agonist-induced activation of eNOS in vitro and in vivo, through the enzyme's release from its allosteric inhibitory interaction with caveolin. 30 Importantly, this may not be accompanied with further nitrosative stress, as produced with complete abrogation of Cav-1 expression, 31 because the residual caveolin expression maintains a physiological activation of eNOS (see Figure 4A ), as opposed to deregulated NO production. Therapeutically, this can be achieved using statins, that we showed to produce a similar 40% to 50% downregulation of endothelial Cav-1 in vitro and improvement in endothelial function in vivo. 17, 18 Downregulation of Cav-1 may also decrease ROS production in vascular smooth muscle cells, in addition to eNOS regulation in endothelium.
In conclusion, the present study revealed the importance of Cav-1 for NADPH oxidase activation in response to AII in ECs, as well as of the spatial confinement of O 2
Ϫ⅐ production both for eNOS activation and its uncoupling. It also demonstrates the possibility of preventing eNOS uncoupling by moderate Cav-1 downregulation, opening the possibility to therapeutically modulate the adverse effects of the reninangiotensin system in vascular disease. Ϫ⅐ production that (1) activates eNOS activity (through ROS-sensitive intracellular signaling; see Figure  2 ) but also (2) produces eNOS uncoupling, thereby shifting some eNOS to monomeric form producing more O 2
Ϫ⅐ , resulting in endothelial dysfunction. Right: Moderate Cav-1 downregulation (as in haploinsufficient Cav-1 ϩ/Ϫ mice). Top right: The abundance of Cav-1 is decreased, but eNOS confinement is unchanged in caveolae (see Figure 3 ). Bottom right: On AII stimulation, less p47phox is recruited, resulting in lower NADPH oxidase activation and less O 2
Ϫ⅐ production in caveolae (see Figure  3 ); this (1) lowers ROS-dependent activation of eNOS but (2) prevents eNOS uncoupling, resulting in preserved NO bioavailability and endothelial function.
